Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

NCT00084318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

238

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
DRUG: docetaxel
RADIATION: radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]